Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe private monthly cost of Wegovy in the UK varies by dose and provider, but legitimate treatment typically runs from around £150 to £375 or more per month — a range that reflects dose level, what's bundled in, and how different services structure their pricing. Wegovy is a prescription-only medicine; a prescriber must assess whether it is clinically suitable for you before any treatment begins. If you've been scanning prices online and found the numbers confusing, or wildly different from one site to the next, that confusion is completely reasonable. The market is messy. This page explains why, and what to look for.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misconception in this space is that the monthly figure advertised by a private provider is the full cost. It rarely is. Many services quote the medicine price alone, then add consultation fees, prescription charges, and delivery on top. Some charge separately for aftercare calls or dose-review support. Others put you into a subscription that auto-renews and is awkward to pause.
The honest picture is that UK private Wegovy pricing spans a wide range at each dose level. Eli Lilly's list price for tirzepatide rose sharply in September 2025, and Novo Nordisk's supply economics follow a different but similarly shifting pattern. As widely reported, the private market for GLP-1 medicines is still finding its level. Any figure you see should prompt the question: what exactly does that include? A price that looks low on a comparison screenshot often looks different once you add what was missing.
NICE's recommendation for semaglutide (Wegovy) under appraisal TA875 outlines the clinical criteria for its use, worth reading if you want to understand how the evidence base for this medicine was assessed, independently of the pricing question.
A reasonable all-in private price includes: a clinical consultation, a prescription written by a qualified prescriber, the medicine itself, and delivery. Aftercare (meaning someone you can actually contact if you feel unwell or have questions during treatment) should also be part of the package, not an upsell.
The titration schedule for Wegovy means you will move through multiple doses over several months. Some providers charge differently at each stage; others hold pricing flat. It's worth checking whether the price you're quoted covers your current dose or the maintenance dose you'll eventually reach, because the two can differ significantly. For a fuller breakdown of how private payment works across the dose journey, the guide to paying privately for Wegovy covers this in detail.
At nume, one transparent price covers the consultation, prescription, treatment, and free next-working-day delivery. There are no subscription tiers and no auto-renewals. Every repeat order goes through a fresh clinical review before anything is dispatched. We are not the cheapest option in the market, that's a deliberate choice, not an oversight. What you're paying for is a GPhC-registered pharmacy, a prescriber who reads your notes rather than an algorithm processing them, and a supply chain we can account for at every step.
Price is a reasonable thing to think about. These medicines cost real money, taken over months or years, and nobody should pretend otherwise. But for a prescription-only medicine, the cheapest listing answers a different question than the one you actually need answered.
The MHRA has warned publicly about counterfeit weight-loss pens sold online, including fake Wegovy and semaglutide products that have contained entirely different substances. Prices far below the realistic market range, sellers operating without a verifiable pharmacy registration, and offers of semaglutide without a clinical assessment are all patterns worth avoiding. You can verify any online pharmacy's legitimacy on the GPhC register in under a minute, the registration number should be findable on the provider's site. Ours is 9012878.
The NHS patient information for semaglutide is also worth bookmarking: it covers what to expect from the medicine, the side effects most commonly reported, and when to seek medical advice, all of which matter more, practically, than a price comparison. For questions about how the NHS route for Wegovy compares with going private, the NHS vs private cost breakdown sets out the differences clearly.
If you'd like to understand the full picture of what private Wegovy costs at each dose stage, our Wegovy pricing overview has the detail, and you can read more about the treatment itself on our Wegovy information page. When you're ready to speak with a prescriber, start your free consultation here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.